Shockwave Medical (SWAV) Announces 1.7M Share Proposed Public Offering of Common Stock

Shockwave Medical, Inc. (“Shockwave”) (Nasdaq: SWAV) today announced it has commenced an underwritten public offering of 1,700,000 shares of its common stock. All of the shares of common stock are being offered by Shockwave. In addition, Shockwave intends to grant the underwriters a 30-day option to purchase up to an additional 255,000 shares of its common stock. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Morgan Stanley and BofA Securities are acting as joint lead book-running managers for the offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission (the “SEC”) and became automatically effective upon filing.

You May Also Be Interested In

• Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
• Tungray Technologies (TRSG) Closes $5M IPO
• Momentus Inc. (MNTS) Receives Nasdaq Deficiency Notice